Reactive oxygen species (ROS) have been implicated in skin tumor promotion. Earlier, we showed that porphyrinmediated cutaneous photosensitization results in the in situ generation of ROS. Recently, we have provided the first in situ evidence for the involvement of ROS in stage I tumor promotion. In this study we further show that in situgenerated ROS act as weak complete tumor promoters in 7,12-dimethylbenz[a]anthracene (DMBA)-initiated mouse skin. Papillomas were induced in Swiss albino mice by a single topical application of DMBA as initiator. The promotion was achieved in these mice by the sustained generation of ROS through dihematoporphyrin ether (DHE)-mediated cutaneous photosensitization, which was done once every day (six times a week) for 24 weeks. The first appearance of visible papillomas could be recorded 24 weeks after the initiation. The highest tumor incidence of 60% occurred at a dose of 2.5 mg/kg body wt DHE. Increasing the dose of DHE produced a decrease in the incidence as well as in the number of papillomas. In contrast, the number of carcinomas/mouse increased with increasing dose of DHE. Histopathology of the tumor samples indicated the formation of in situ carcinoma also in skin. ROS generated through DHE-mediated photosensitization resulted in ã 3 fold induction of ODC activity 9 h after photosensitization. DHE-mediated photosensitization enhanced [ 3 H]thymidine incorporation in cutaneous DNA in a dosedependent manner. A maximum 5-fold induction of [ 3 H]thymidine incorporation was observed at a dose of 10 mg/kg body wt DHE. The longer latency period, low incidence of tumor induction, low tumor yield and low induction of ODC activity as compared with TPA represent the weak but complete tumor promoting potential of in si/u-generated ROS. The low tumor incidence and tumor yield observed at higher doses of DHE may be due to the ablation of tumors at early stages due to the strong photodynamic action of DHE. Our data indicate that porphyrin-mediated photosensitization has a weak tumor promoting effect in mouse skin and in situ -generated ROS may play an important role in the development of this response.
Introduction
The promotion stage in multistep cutaneous chemical carcinogenesis leads to the development of visible lesions known as papillomas (1) . This is achieved by the selection and clonal
•Abbreviations: ROS, reactive oxygen species; TPA, 12-0-tetradecanoylphorbol-13-acetate; DMBA, 7,12-dimethylbenz [a] anthracene; PMSF, phenylmethylsulfonyl fluoride; DTT, dithiothreitol; DHE, dihematoporphyrin ether, ODC, omithine decarboxylase.
proliferation of initiated cells (2) . The mechanism of tumor promotion has not been fully defined. However, it is known that many tumor promoters acting through the generation of reactive oxygen species (ROS*) produce oxidative stress in the tissue and provide a mitogenic stimulus leading to cellular proliferation (3) . However, most of the evidence that has been provided for the involvement of ROS in tumor promotion is indirect. This includes inhibition of tumor promotion by the prior application of antioxidants and free radical quenchers and scavengers to the skin of mice receiving multiple treatments of a tumor promoter (4, 5) , correlation of potency of tumor promoters with their ability to induce an oxidative burst in PMN (6) and the ability of organic peroxides and hydroperoxides to promote tumors which are initiated by the single application of a chemical carcinogen (7, 8) . In addition, decreased activities of superoxide dismutase, catalase and glutathione reductase following a single skin application of the phorbol ester tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) (9) and an excessive generation of hydrogen peroxide in microsomes following TPA treatment (10) support the concept that ROS are associated with tumor promotion. We have shown that organic hydroperoxides/peroxides can be metabolized by human skin keratinocytes to free radicals (11). In mouse skin keratinocytes and in intact mouse skin these peroxy compounds can also be metabolized to free radicals (12, 13) . Besides, in cell culture systems, xanthine/xanthine oxidase-generated ROS have been shown to transform mouse embryo fibroblast cells (14) . However, so far no direct evidence has been given for the involvement of ROS in skin tumor promotion. Recently, we showed that in 5/r«-generated ROS result in the development of cutaneous inflammation, epidermal hyperplasia, glandular hyperplasia and neutrophil infiltration, which are assumed to be some of the characteristic changes associated with stage I tumor promotion in murine skin (15) . In this study, we show that porphyrin-mediated photosensitization has a weak tumor promoting effect in mouse skin. The in si'M-generated ROS as a result of cutaneous photosensitization may play an important role in this tumor promoting response. of 0.725 mg/ml in normal saline (pH 7.4) was injected l.p. into mice at different dose levels after appropriate dilution to maintain a constant injection volume of 10 ml/kg body wt.
Materials and methods

Materials
Irradiation procedure
Mice were irradiated in individual cages of plexiglass at a source-target distance of 20 cm. The mice were irradiated 6 h after the injection of DHE, since it has been shown that at this time point substantial dye uptake occurs in skin (18) . The light source used was a 600 W tungsten filament lamp delivering a dose of 800 lux/unit area at the target distance.
Treatment of animals and tumor studies
Mice which were at the resting phase of the hair cycle were divided into seven groups of 20 animals each. The dorsal skin of these animals was initiated with a single topical application of 40 |ig DMBA in 200 (il acetone under subdued light. A week after initiation, three groups of animals received a weekly i.p. injection of DHE at three different dose levels of 1.25, 2 5 and 5.0 mg/kg body wt for 10 weeks. The selection of dose regimen is based on our previously published studies (19) . Two groups of animals received only saline and served as controls. One group of animals receiving 5.0 mg/kg body wt DHE was kept away from the intense light and served as a dark control. One group of animals was treated with 5 nmol TPA in 200 |il acetone twice weekly for 22 weeks. Three groups of DHE-treated and one group of control animals were irradiated for 1 h every day (six days a weak) continuously for 24 weeks. Though DHE was administered for only 10 weeks, the selection of 14 weeks irradiation time period beyond 10 weeks is based on the fact that DHE remains accumulated in skin and stays there for several weeks. This leads to the extended cutaneous photosensitivity in response to light (20) . Thus the irradiation of mice for a further period of 14 weeks after the cessation of DHE administration might lead to a sustained generation of ROS in skin during this time period. The animals were observed for the appearance of papillomas. The irradiation was stopped after the first appearance of tumors was recorded. The criteria for the diagnosis of various tumors were as described earlier (21) . In brief, papillomas are cauliflower like exophytic rumors with a narrow or broad base consisting of a series of connective tissue folds covered by stratified squamous epithelium, usually without cellular atypia. The number of papillomas was counted weekly. The data are expressed as the percentage of mice with papillomas and the number of papillomas per mouse and are plotted as a function of weeks on test. The number of suspected carcinomas was counted weekly and verified histopathologically at the conclusion of the experiment at 48 weeks. Squamous cell carcinomas are composed of very irregular endophytic epithelial growths with frequent cellular atypia. They are usually very differentiated, with the formation of keralinized layers of homy pearls (22) . The data are expressed as the percentage of mice with carcinoma and the number of carcinomas per mouse.
Ornithine decarboxylase (ODC) activity assay
In this study eight groups of six animals each were used. Two groups of animals received an i.p. injection of saline and served as controls. Five groups received i.p. injections of DHE at a dose level of 5 mg/kg body wt. The remaining one group of animals received a topical application of 5 nmol TPA in 200 |il acetone. One of the DHE-treated groups was protected from light exposure by keeping them in the dark and served as a dark control. One of the saline-treated and all the DHE-treated groups except the dark control group were irradiated for 2 h. All groups of animals except the TPA-treated group were killed at different time intervals after irradiation by cervical dislocation. TPA-treated animals were killed 6 h after the treatment, as it is known from earlier studies that maximum induction of ODC activity occurs at this time point (23) . The dorsal skin was removed and kept epidermal side down on a covered glass Petri dish containing crushed ice. The skin was scraped with a sharp scalpel blade to remove subcutaneous fat and muscle. The skin of the two animals was pooled, minced and homogenized in 5 ml 50 mM Tris-HCl buffer, pH 7.5, containing 0.1 mM DTT, 0.1 mM EDTA, 1.0 mM PMSF, 0.1 mM pyridoxal phosphate, 1.0 mM 2-mercaptoethanol and 0.1% Tween-80 at 4°C using a polytron homogenizer (Kinematics AGPT 3000). The epidermal homogenate was centnfuged at 9000 g for 20 min and then the resulting supernatant was centnfuged in an ultracentrifuge at 105 000 g for 1 h at 4°C. ODC activity was assayed in this supernatant by the method of O'Brien et al. (23) as described by Verma el al. (24) . In brief, the reaction mixture contained 400 |il enzyme and 95 (il cofactor mixture containing 0.32 mM pyridoxal phosphate, 0.4 mM EDTA, 4.0 mM DTT, 0.4 mM omithine, 0.02% Brij-35 and 0.05 (iCi [ l4 C]omithine in a total volume of 0.495 nl. After the additions were complete, the reaction mixture tubes were covered immediately with a rubber bung containing 0.2 ml ethanolamine and methoxyethanol (2:1) mixture in the central well and incubated in a shaking water bath at 37°C for 1 h. The reaction was terminated by injecting 1 ml 2 M citric acid along the sides of the glass tubes and the incubation was continued for 1 h to ensure complete absorption of of the central well were transferred to a vial containing 2 ml ethanol. Toluenebased scintillation fluid (10 ml) was added and radioactivity was counted in a liquid scintillation counter (LKB-Wallace-1410). ODC activity was expressed as pmol
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CO2 released/h/mg protein. Protein was determined by the Lowry's method using bovine serum albumin as standard.
Quantitation of epidermal DNA synthesis
In this study six groups of six animals each were used. Two groups of animals received an i.p. injection of saline and four groups of animals received a DHE injection at various dose levels, namely 2.5, 5 and 10 mg/kg body wt. One group of animals receiving the 5 mg/kg dose of DHE was kept in the dark and served as a dark control. All the DHE-treated animals except the dark control and one of the saline-treated groups were irradiated for 2 h. Eighteen hours after irradiation, animals of all the six groups were injected with 30 \\C\ 
Histopalhological study
Tumor samples from the tumor-bearing mice were taken at the end of 48 weeks and fixed in 10% buffered formalin. Hematoxylin and eosin preparations of the processed sections were prepared for microscopic examination.
Results
The effect of repeated DHE-mediated photosensitization on DMBA-initiated skin of mice is shown in Figure 1 . Figure la demonstrates the effect of repeated photosensitization on percent incidence of tumors in mice. The first appearance of tumors could be recorded 24 weeks after initiation. The incidence of tumor induction at this time point was ~15% in mice receiving 1.25 mg/kg body wt DHE as photosensitizing agent. However, at the dose level of 2.5 mg/kg body wt the incidence increased to ~22%. A further increase in the dose of DHE had no significant effect on the incidence of tumors, nevertheless, it was about the same as could be observed with the lowest administered dose. The maximum incidence of tumors was around 29 weeks after the beginning of tumor promotion. At this time point at a dose level of 1.25 mg/kg body wt papillomas could be observed in 30% of mice, whereas at the dose level of 2.5 mg/kg body wt it was ~60%. However, at a dose of 5 mg/kg body wt the incidence decreased to 40%. The observations were recorded up to 38 weeks and it was found that tumor incidence in mice receiving higher doses of DHE decreased significantly, perhaps due to the ablation of tumors formed at a very early stage. Figure lb shows the growth of papillomas in mice represented as no. of tumors/ mouse. At the beginning of the 24 weeks at a dose level of 1.25 mg/kg body wt there were ~0.6 tumors/mouse, which increased to 1.3 tumors/mouse by week 29 and thereafter decreased to a level of 1.0 tumor/mouse by week 38. The higher doses of DHE showed a decrease in the number of skin tumors such that at a dose level of 2.5 mg/kg body wt the maximum number was 1.2 tumors/mouse, whereas at the dose of 5.0 mg it was 0.8 tumors/mouse. At the end of 38 weeks the tumor count decreased significantly in both the groups tõ 0.7 and 0.3 tumors/mouse respectively. The animals treated with DHE but not irradiated (dark controls) did not show any incidence of tumorigenesis. Similarly, animals exposed to light alone had no incidence of tumors during the time period of observation.
The effect of DHE-mediated photosensitization on ODC induction is shown in Figure 2 . DHE skin photosensitization results in the induction of ODC activity, which is ~3-fold as compared with dark-or light alone-treated controls. ODC activity induction was substantially less as compared with TPA-mediated ODC induction. The time-response relationship of ODC induction is shown in the inset of Figure 2 . The maximum induction could be observed at ~9 h following DHE-mediated photosensitization. Table I shows a summary of the data on the percentage incidence of papillomas, number of papillomas and number of carcinomas, along with the latency period of their induction in DHE-and TPA-treated groups. From the data, the relative potential of ROS generated by DHE-mediated photosensitization and TPA can be visualized. In the case of TPA, the latency period for tumor induction was only 6 weeks, whereas for DHE-treated groups it was 24 weeks after the initiation of tumor promotion. Similarly, the tumor yield and the percentage incidence of tumors were much higher in the TPA-treated group. The number of carcinomas formed in the DHE treatment groups, in contrast to number of papillomas, was higher with the higher dose of photosensitizer, though it was substantially lower than the TPA treatment group.
Typical representative samples of skin tumors counted as papillomas and carcinomas were confirmed histopathologically. These results indicate that most of the malignant tumors were squamous cell carcinomas. Figure 4 shows the histopathology of skin initiated with DMBA and promoted by repeated DHEmediated photosensitization. Figure 4A carcinoma formation in the apparently uninvolved skin. Some of the carcinomas have superficial papillary projections, shown in Figure 4B .
Discussion
In our previous studies we have shown that porphyrin-mediated cutaneous photosensitization results in the in situ generation of ROS in skin (26) (27) (28) . This model has been utilized in the present study to demonstrate the role of in ^(7«-generated ROS in skin tumor promotion. The available evidence for the involvement of ROS in tumor promotion, such as the demonstration that skin keratinocytes can metabolize organic peroxides/hydroperoxides to free radicals (7, (11) (12) (13) and the generation of ROS by skin application of tumor promoters, is rather indirect. Recently, we have also shown, using the porphyrin-mediated skin photosensitization model, that in 5i7«-generated ROS can result in the pathological changes characteristic of stage I tumor promotion in mouse skin (15) . Further to this, in the present communication we show that in DMBA-initiated skin, complete tumor promotion can be achieved by the persistent in situ generation of ROS, although the latency period for the induction of tumors was found to be much longer as compared with TPA-mediated tumor promotion. The observed longer latency period may be due to the low potency of ROS to promote skin rumors as compared with TPA. Further, a low tumor promoting potential of ROS is evident from the low percentage incidence of tumor induction and the low tumor yield as compared with that observed for TPA in the present study. However, the decrease in tumor incidence and tumor yield observed at the higher doses of DHE may be the result of ablation of tumors at an early stage due to the strong photodynamic action of DHE at the higher dose. These data are consistent with our previous observations, where we have shown that at the 5.0 mg dose level of DHE, substantial tumor ablation occurs after the exposure of mice to a suitable dose of light (18, 20) . Similar to other tumor promoters, in s/Tw-generated ROS induced ODC activity and enhanced [ 3 H]thymidine incorporation into epidermal DNA, suggesting that in sffM-generated ROS have a definite tumor promoting potential. The smaller magnitude of ODC induction and enhancement of [ 3 H]thymidine incorporation are analogous to the tumor incidence and tumor yield data when compared with TPA, further corroborating the fact that ROS are weak complete tumor promoters in skin. Similar induction of ODC activity has been observed in primary murine keratinocytes following their exposure to xanthine/xanthine oxidase, which generate superoxide anion (29) . In addition, xanthine/xanthine oxidase-generated superoxide anions have been shown to induce anchorage-independent growth of JB6 epidermal cells (14) . The present study also substantiates previously published observations in epidermal cells strongly implying the involvement of ROS in the promotion stage of skin tumorigenesis. The increase in the incidence and yield of carcinomas with increasing dose of DHE may be due to the higher production of ROS with increasing dose of DHE during cutaneous photosensitization. This is based on our previously published observations where skin applications of organic hydroperoxides/peroxides to papilloma-bearing mice led to an enhanced malignant transformation of benign papillomas into carcinomas (21) .
The mechanism by which ROS may promote tumor induction is not known. However, ROS, being highly reactive, are able to cause DNA strand breaks (30, 31) , sister chromatid exchange, chromosomal abnormalities (32,33), cellular transformation (34, 35) , mutations in DNA (36) and induction of protooncogenes such as myc and fos (37) . Recently, induction of protooncogenes has also been demonstrated following porphyrin photosensitization, suggesting a role for ROS in the expression of protooncogenes (38) . To sum up, our data indicate that porphyrin-mediated photosensitization has a weak tumor promoting effect in murine skin and that in situgenerated ROS play an important role in this process.
